# OnCo record constantine-tam (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/constantine-tam/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "constantine-tam" ;
  schema:name "Constantine S. Tam"@en ;
  schema:description "Led the zanubrutinib SEQUOIA trial and the first ibrutinib-venetoclax study in mantle cell lymphoma."@en ;
  schema:url <https://onco.cc/people/constantine-tam/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Tam%20CS%5BAuthor%5D%20zanubrutinib%20OR%20ibrutinib%20venetoclax> ;
  onco:tag "cll", "btk", "australia" ;
  schema:jobTitle "Head of Lymphoma Service, Alfred Health; Professor of Haematology, Monash University" ;
  schema:sameAs <https://orcid.org/0000-0002-9759-5017> ;
  onco:cancers <https://onco.cc/cancers/cll/>, <https://onco.cc/cancers/mantle-cell-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/bcl2/> ;
  onco:drugs <https://onco.cc/drugs/venetoclax/> ;
  onco:institutions <https://onco.cc/institutions/alfred-health-monash/> ;
  onco:trials <https://onco.cc/trials/sequoia/> ;
  schema:affiliation <https://onco.cc/institutions/alfred-health-monash/> .